The Translational Asian Age-related Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care
About this episode
The episode discusses the TAAP-2 program's efforts to address age-related macular degeneration in Asia.
Age-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older adults worldwide. In Asia, where populations are ageing rapidly, its impact is particularly profound. For many, the disease quietly erodes central vision, making everyday activities such as reading, driving, and recognising faces increasingly difficult. Against this backdrop, the Translational Asian Age-related Macular Degeneration Programme, or TAAP for short, has emerged as a bold and ambitious effort to confront the disease head-on. Now in its second phase, TAAP-2 represents a significant evolution in both scientific scope and clinical ambition.
More episodes of SciPod
- The Missing Piece in Medical Diagnostics: Why the Right Samples Matter
- Sleeping More Than Ever Before: The Surprising Science of Extra Sleep and Anxiety
- The Hidden Signals of the Heart: How Genetics Is Transforming the Fight Against Sudden Cardiac Death
- The Brain’s Hidden Chemistry: What the Hippocampus Reveals About Memory, Energy, and Disease
- When “Safe” Isn’t Safe Enough: What Hidden Fungal Toxins in Cannabis Could Mean for Public Health
- Reading Ancient Pollen to Reconstruct a Lost World in Java
Explore listener stats, chart rankings, contacts and more on the SciPod podcast page.